NCT06727552 A Study of Barzolvolimab in Patients With Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06718101 A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06701331 Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06700499 A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06687512 A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients. Status NOT_YET_RECRUITING Phase NA
NCT06673654 A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis. Status COMPLETED Phase PHASE1
NCT06627335 An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis Status RECRUITING Phase N/A
NCT06614907 A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent® Status COMPLETED Phase PHASE1
NCT06599411 Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases Status NOT_YET_RECRUITING Phase N/A
NCT06587685 A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis Status RECRUITING Phase PHASE3
NCT06585202 Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06578351 TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM) Status COMPLETED Phase N/A
NCT06564389 FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients Status RECRUITING Phase PHASE1
NCT06553287 Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis. Status COMPLETED Phase PHASE1
NCT06553209 Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT06552520 To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06551363 Atopic Dermatitis Cutaneous Discomfort of the Infant Under the Age of One Year : Analysis of Filmed Sequences (PRE-PRURINEO) Status COMPLETED Phase N/A
NCT06524635 A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab Status RECRUITING Phase PHASE2